Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis

Mathur, VS; Bushinsky, DA; Inker, L; Klaerner, G; Li, E; Parsell, D; Perkovic, V; Stasiv, Y; Walker, M; Wesson, DE; Wheeler, DC; Tangri, N

Tangri, N (通讯作者)，Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Internal Med, Winnipeg, MB, Canada.

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023; 38 (6): 1448

Abstract

Background Whether treating metabolic acidosis slows progression of chronic kidney disease (CKD) has not been established. Veverimer is a novel hydroc......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索